CF community video short series
Finding time to fit CF treatments into your daily schedule can often be hard to manage. In this
video, hear from CF patients and caregivers on how time management is crucial, plus how they
stay motivated and make health a priority. This includes an easy-to-understand explanation of CF
treatments, including Pulmozyme, because an important component of treatments is understanding
how they work. Before the video begins, please answer 2 quick questions that will appear on your
screen, and then we would love your feedback afterwards with a brief survey.
Close
XImportant Safety Information
Contraindications
Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used in
conjunction with standard therapies for CF.
Adverse Reactions
When starting Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest
pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and
short-lived.
Pediatric Use
There is a limited amount of information available concerning the usage of Pulmozyme in patients who are younger than
5 years. The decision to use Pulmozyme in these patients is made after considering the potential for a benefit in
lung function or in decreasing the risk of RTEs.
Important Safety Considerations
The safety of Pulmozyme given by daily inhalation for 2 weeks has been studied using 98 CF patients with 65 of them
aged 3 months to <5 years (younger group) and 33 aged 5 years to ≤10 years (older group). The PARI BABY™
reusable nebulizer (which uses a face mask instead of a mouthpiece)
was used in patients who were unable to show that they could breathe in or out using their mouth throughout the
entire treatment period. There were more reports of cough, moderate to severe cough, runny nose, and rash in the
younger group of patients. Other reported events tended to be of mild to moderate severity. The kind of side effects
reported was similar to that of Pulmozyme when used in the larger trials that studied older patients.
For further information, please see the Pulmozyme full prescribing
information. If you have questions, please discuss them with your CF healthcare team.
Check out additional videos in this series on CF
Living.
